Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 213

    1.

    Pathogenesis of spinally mediated hyperalgesia in diabetes.

    Ramos KM, Jiang Y, Svensson CI, Calcutt NA.

    Diabetes. 2007 Jun;56(6):1569-76. Epub 2007 Feb 7.PMID: 17287466 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Elevated spinal cyclooxygenase and prostaglandin release during hyperalgesia in diabetic rats.

    Freshwater JD, Svensson CI, Malmberg AB, Calcutt NA.

    Diabetes. 2002 Jul;51(7):2249-55.PMID: 12086957 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Impaired formalin-evoked changes of spinal amino acid levels in diabetic rats.

    Malmberg AB, O'Connor WT, Glennon JC, Ceseña R, Calcutt NA.

    Brain Res. 2006 Oct 18;1115(1):48-53. Epub 2006 Aug 22.PMID: 16920081 [PubMed - indexed for MEDLINE]Related articles

    4.

    Tolrestat treatment prevents modification of the formalin test model of prolonged pain in hyperglycemic rats.

    Calcutt NA, Malmberg AB, Yamamoto T, Yaksh TL.

    Pain. 1994 Sep;58(3):413-20.PMID: 7838591 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prevention of sensory disorders in diabetic Sprague-Dawley rats by aldose reductase inhibition or treatment with ciliary neurotrophic factor.

    Calcutt NA, Freshwater JD, Mizisin AP.

    Diabetologia. 2004 Apr;47(4):718-24.PMID: 15298349 [PubMed - indexed for MEDLINE]Related articles

    6.

    Effect of the aldose reductase inhibitor tolrestat on nerve conduction velocity, Na/K ATPase activity, and polyols in red blood cells, sciatic nerve, kidney cortex, and kidney medulla of diabetic rats.

    Raccah D, Coste T, Cameron NE, Dufayet D, Vague P, Hohman TC.

    J Diabetes Complications. 1998 May-Jun;12(3):154-62.PMID: 9618071 [PubMed - indexed for MEDLINE]Related articles

    7.

    Different effects of two aldose reductase inhibitors on nociception and prostaglandin E.

    Calcutt NA, Li L, Yaksh TL, Malmberg AB.

    Eur J Pharmacol. 1995 Oct 16;285(2):189-97.PMID: 8566138 [PubMed - indexed for MEDLINE]Related articles

    8.

    Protection of sensory function and antihyperalgesic properties of a prosaposin-derived peptide in diabetic rats.

    Calcutt NA, Freshwater JD, O'Brien JS.

    Anesthesiology. 2000 Nov;93(5):1271-8.PMID: 11046216 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.
    10.

    Intrathecally administered COX-2 but not COX-1 or COX-3 inhibitors attenuate streptozotocin-induced mechanical hyperalgesia in rats.

    Matsunaga A, Kawamoto M, Shiraishi S, Yasuda T, Kajiyama S, Kurita S, Yuge O.

    Eur J Pharmacol. 2007 Jan 5;554(1):12-7. Epub 2006 Oct 20.PMID: 17112505 [PubMed - indexed for MEDLINE]Related articles

    11.

    Elevated lipid peroxidation and DNA oxidation in nerve from diabetic rats: effects of aldose reductase inhibition, insulin, and neurotrophic factors.

    Cunha JM, Jolivalt CG, Ramos KM, Gregory JA, Calcutt NA, Mizisin AP.

    Metabolism. 2008 Jul;57(7):873-81.PMID: 18555826 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Tactile allodynia and formalin hyperalgesia in streptozotocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine.

    Calcutt NA, Jorge MC, Yaksh TL, Chaplan SR.

    Pain. 1996 Dec;68(2-3):293-9.PMID: 9121817 [PubMed - indexed for MEDLINE]Related articles

    13.

    Mechanical hyperalgesia in rat models of systemic and local hyperglycemia.

    Dobretsov M, Hastings SL, Romanovsky D, Stimers JR, Zhang JM.

    Brain Res. 2003 Jan 17;960(1-2):174-83.PMID: 12505670 [PubMed - indexed for MEDLINE]Related articles

    14.

    Correction of nerve conduction and endoneurial blood flow deficits by the aldose reductase inhibitor, tolrestat, in diabetic rats.

    Cotter MA, Cameron NE, Hohman TC.

    J Peripher Nerv Syst. 1998;3(3):217-23.PMID: 10959252 [PubMed - indexed for MEDLINE]Related articles

    15.

    Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat.

    Fox A, Eastwood C, Gentry C, Manning D, Urban L.

    Pain. 1999 Jun;81(3):307-16.PMID: 10431718 [PubMed - indexed for MEDLINE]Related articles

    16.

    Cyclooxygenase-2 is induced in the endothelial cells throughout the central nervous system during carrageenan-induced hind paw inflammation; its possible role in hyperalgesia.

    Ibuki T, Matsumura K, Yamazaki Y, Nozaki T, Tanaka Y, Kobayashi S.

    J Neurochem. 2003 Jul;86(2):318-28.PMID: 12871573 [PubMed - indexed for MEDLINE]Related articles

    17.

    Elevated substance-P-like immunoreactivity levels in spinal dialysates during the formalin test in normal and diabetic rats.

    Calcutt NA, Stiller C, Gustafsson H, Malmberg AB.

    Brain Res. 2000 Feb 21;856(1-2):20-7.PMID: 10677607 [PubMed - indexed for MEDLINE]Related articles

    18.

    Mechanical hyperalgesia in streptozotocin-diabetic rats.

    Ahlgren SC, Levine JD.

    Neuroscience. 1993 Feb;52(4):1049-55.PMID: 8450973 [PubMed - indexed for MEDLINE]Related articles

    19.

    Mitogen-activated protein kinase p38 mediates reduced nerve conduction velocity in experimental diabetic neuropathy: interactions with aldose reductase.

    Price SA, Agthong S, Middlemas AB, Tomlinson DR.

    Diabetes. 2004 Jul;53(7):1851-6.PMID: 15220210 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia.

    Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL, Webb M.

    Eur J Neurosci. 2005 Nov;22(10):2431-40.PMID: 16307586 [PubMed - indexed for MEDLINE]Related articles